experienced laboratory staff and the false-positive rate of 0 83 % is considered acceptable. It is important to follow up weak as well as strongly positive reactions to the BM test strip.
Cystic fibrosis (CF) is a serious inherited disorder affecting one infant in 2000 in this country. It is characterised by repeated chest infections, malabsorption secondary to pancreatic insufficiency and a raised salt content in the sweat. At the present time, the state of progression of the lung damage is a major factor in determining prognosis, although nutritional problems are becoming increasingly important as prolonged survival becomes more common.
There is now considerable evidence for improved duration and quality of life among children in whom the diagnosis has been made early, before progressive lung disease is advanced and the general condition compromised by nutritional deficiencies.' Furthermore, comparisons of the fate of second siblings in whom the diagnosis has been made at birth, with the first sibling in the family, supports the advantages of early diagnosis.2 While potentially this could be effected by means of a neonatal screening programme, no method has so far been available which is free from unacceptably large numbers of both falsepositive and -negative reactions.
One possible screening test for CF has been advocated based upon Eight false-positive results were associated with the presence of blood in the meconium (usually visible on inspection) and 19 with the presence of meconium "plug" material.
Lactase activity was demonstrated in no less than 29 of 79 specimens from infants who eventually proved to be normal.
Discussion
Of the seven CF infants detected in this series, three could have been identified as siblings of known patients or because of meconium ileus. However, in the remaining four there was no reason to suspect the diagnosis. As a direct result of the screening programme, prompt treatment and genetic advice were given.
The detection rate is in keeping with the known frequency of the disease.'3 Extensive enquiries to all the paediatricians in our region have, so far, failed to reveal any evidence of a missed patient from among the infants screened, but, since pancreatic function is alleged to be near normal in 10 % of CF children, it is possible that this proportion will be missed by tests such as this which are based on meconium abnormalities. Other authors have reported a falsenegative rate of up to 25 %,5 7 but we believe that many of these poor results are due to the test being performed on wards by large numbers of inexperienced and uninvolved staff. We would emphasise the need for tests to be carried out centrally and by experienced laboratory workers.
We also regard as essential the full investigation of infants who give a weak-positive BM test. The acceptance of the manufacturer's definition that only a strong blue is indicative of a positive reaction would have resulted in our missing one of the present CF cases.
The test has been criticised because of an unacceptably high false-positive rate.7 In our hands, however, the frequency of false-positives was only 0-83 %. We consider this acceptable although it necessitates evaluation of a significant number of unaffected infants and the parental anxiety engendered is a continuing problem. Up to the present time sweat tests and faecal chymotrypsin estimations combined with clinical assessment have allowed a reliable diagnosis to be established within a few weeks. The faecal chymotrypsin values have been particularly helpful (Table) .
It is possible that in the future immunoreactive trypsin estimations on babies who have a positive BM test will allow an even more rapid evaluation. 1415 We 
